• Intravesical p21 mRNA-LNP Therapy in Bladder Cancer

  2026-08-14

  This FASEB Journal study develops chemically modified p21 mRNA encapsulated in lipid nanoparticles for localized intravesical treatment of bladder cancer. The work links tumor-suppressor restoration to cell-cycle inhibition, DNA-damage signaling, apoptosis, bladder-localized expression, and tumor suppression in an orthotopic mouse model.

• Fluoxetine HCl: Serotonergic Mechanisms & Research

  2026-08-14

  Fluoxetine HCl is a selective serotonin reuptake inhibitor used to examine serotonin transporter activity, 5-HT2C receptor signaling, neurogenesis, and behavior. Its research value depends on separating acute receptor assays from chronic plasticity models and developmental exposure paradigms.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP) for Cell Assays

  2026-08-13

  Learn how SKU R1011, EZ Cap™ Cy5 EGFP mRNA (5-moUTP), separates mRNA uptake from functional translation in viability, proliferation, cytotoxicity, and macrophage delivery studies. This scenario-based guide covers assay design, handling, data interpretation, and practical product selection using product specifications and published nanoparticle evidence.

• FITC-Concanavalin A (ConA) Workflow Guide

  2026-08-13

  FITC-Concanavalin A is a fluorescent lectin conjugate for detecting accessible α-D-glucose and α-D-mannose residues in cell-surface and tissue samples. It is intended for carbohydrate-focused immunofluorescence staining and flow cytometry workflows, not for non-carbohydrate targets or use outside the stated storage and stability conditions.

• FITC-Concanavalin A (ConA) Conjugate Guide

  2026-08-12

  FITC-Concanavalin A (ConA) Conjugate is a fluorescent lectin probe for visualizing α-D-glucose and α-D-mannose residues on cell surfaces, tissue sections, and other glycoprotein-rich samples. It is suited to immunofluorescence, flow cytometry, and glycobiology workflows, but should not be interpreted as a universal glycan stain or used outside validated carbohydrate-binding assays.

• ECL Chemiluminescent Substrate Detection Kit Workflow

  2026-08-12

  Apply hypersensitive HRP chemiluminescence to low-abundance immunoblots, including mitochondrial and ER-remodeling studies in trigeminal neuron–glia models. This workflow combines extended signal availability, low background, and practical exposure strategies for reliable protein detection on nitrocellulose or PVDF membranes.

• Dovitinib (TKI-258) Cancer Research Workflows

  2026-08-11

  Build reproducible RTK-inhibition experiments with Dovitinib across hematologic and solid-tumor models, while separating pathway suppression from nonspecific toxicity. This workflow connects dose-response testing, ERK/STAT readouts, apoptosis assays, and immune-signature profiling for more informative translational studies.

• BIRC2 and BIRC3 Regulation in Pulmonary Epithelium

  2026-08-11

  Thorne et al. show that inflammatory cytokines and glucocorticoids regulate BIRC2 and BIRC3 differently in pulmonary epithelial models. The work identifies BIRC3 as a strongly inducible, potentially protective response, while relatively stable BIRC2 may support rapid signaling functions.

• Gramine Drives Ferroptosis in TNBC via CUL3–MTDH

  2026-08-10

  This study identifies a CUL3–MTDH ubiquitination pathway through which the natural indole alkaloid gramine suppresses triple-negative breast cancer by promoting ferroptosis. Its combination of target-engagement assays, ferroptosis rescue experiments, genetic perturbation, and xenograft validation provides a mechanistic framework for evaluating gramine as a candidate strategy in chemoresistant TNBC.

• Masitinib (AB1010): KIT/PDGFR Workflow Guide

  2026-08-09

  Masitinib (AB1010) is a DMSO-compatible kinase inhibitor for research involving KIT, PDGFRα, PDGFRβ, mast cell responses, and selected KIT-mutant cell models. It is not appropriate for aqueous or ethanol-based workflows, broad-spectrum kinase screening, or direct clinical use without separately validated evidence.

• Inonotus hispidus Polypeptide in Periodontitis

  2026-08-08

  A January 2025 study found that a purified polypeptide fraction from Inonotus hispidus combined antibacterial, anti-inflammatory, microbiome-associated, and bone-protective effects across cellular, animal, and human investigations. Its findings implicate β-catenin/NF-κB signaling as a possible mechanism for limiting inflammatory alveolar bone loss, while also highlighting the need for more detailed translational validation.

• Roscovitine (Seliciclib) and Tumor Immunity

  2026-08-07

  Roscovitine (Seliciclib, CYC202) offers translational researchers a defined way to interrogate CDK-driven cell-cycle control alongside radiotherapy and checkpoint blockade. This article separates established evidence from forward-looking hypotheses and outlines how to evaluate cell-cycle arrest, tumor control, immune remodeling, and experimental readiness.

• Meta-Analysis: Azilsartan Medoxomil Monopotassium in BP Redu

  2026-08-07

  This systematic review and network meta-analysis rigorously assessed the efficacy of azilsartan medoxomil (TAK 491) against other antihypertensive agents in lowering blood pressure among mild-to-moderate hypertensive patients. The results demonstrate that azilsartan medoxomil, especially at 80 mg, outperforms other first-line treatments, providing robust evidence to inform essential hypertension treatment research.

• Modeling Human SAN-Neural Maturation with PSC-Derived Assemb

  2026-08-06

  This study establishes a human in vitro model integrating pluripotent stem cell-derived sinoatrial node and cardiac plexus assembloids, enabling the functional dissection of neuro-cardiac crosstalk during pacemaker maturation. The platform advances understanding of neuron-to-pacemaker signaling pathways critical for both physiological cardiac rhythm and conduction disease mechanisms.

• Angiotensin Peptides Potentiate SARS-CoV-2 Spike–AXL Interac

  2026-08-06

  Oliveira et al. (2025) identify that naturally occurring angiotensin peptides, including fragments like H2N-Ile-His-Pro-OH, significantly enhance SARS-CoV-2 spike protein binding to the AXL receptor. This mechanistic finding bridges renin-angiotensin system research and viral pathogenesis, revealing new perspectives for both cardiovascular and COVID-19 studies.

8079 records 2/539 page Previous Next 12345 下5页 Last page